GDUFA Goals Include Complete Response Letter Meetings, QbD for Generics

The FDA has agreed to schedule 30-minute teleconferences with generic-drug makers upon request to discuss complete response letters under the proposed Generic Drug User Fee Act (GDUFA) goals letter.
Drug Industry Daily